By Counterforce Health Team in Arcalyst (rilonacept) —

Do You Qualify for Arcalyst (rilonacept) Coverage by UnitedHealthcare in California? Decision Tree & Next Steps

Quick Answer: If you have CAPS, DIRA, or recurrent pericarditis and have failed colchicine/NSAIDs, you likely qualify for Arcalyst coverage through UnitedHealthcare in California. Submit prior authorization through your specialist with documented treatment failures. If denied, California's strong Independent Medical Review process overturns ~68% of specialty drug denials. Start with a cardiologist or rheumatologist consultation today.

Table of Contents

How to Use This Decision Tree

This guide helps you determine whether you qualify for Arcalyst (rilonacept) coverage through UnitedHealthcare in California and provides the fastest path to approval. Work through the eligibility triage below, then follow the appropriate action path.

Note: This applies to UnitedHealthcare HMO and PPO plans regulated by California's Department of Managed Health Care (DMHC). Self-funded employer plans follow federal ERISA rules and may have different processes.

Eligibility Triage

✅ Likely Eligible

You probably qualify for coverage if you meet ALL of these criteria:

  • Confirmed diagnosis of CAPS (FCAS/Muckle-Wells), DIRA, or recurrent pericarditis with ≥2 episodes
  • Specialist prescriber (cardiologist for pericarditis; rheumatologist/immunologist for CAPS/DIRA)
  • Failed or intolerant to required step therapy (colchicine, NSAIDs, corticosteroids)
  • Elevated inflammatory markers (CRP/ESR) or genetic confirmation for CAPS/DIRA
  • Age requirements met (≥12 years for recurrent pericarditis; ≥10 kg for DIRA)

⚠️ Possibly Eligible

You may qualify with additional documentation if:

  • Diagnosis is confirmed but step therapy incomplete (haven't tried required medications for adequate duration)
  • Primary care prescriber without specialist consultation
  • Unclear treatment history or missing documentation of prior failures
  • Normal inflammatory markers but clinical symptoms consistent with diagnosis

❌ Not Yet Eligible

Coverage unlikely without changes if:

  • No confirmed diagnosis of FDA-approved indications
  • Alternative effective treatments haven't been attempted
  • Contraindications to Arcalyst (active infection, live vaccines)
  • Non-specialist prescriber without documented consultation

If "Likely Eligible" - Document Checklist

Required Documentation

Gather these documents before submitting your prior authorization:

Medical Records

  • Specialist consultation note with clear diagnosis and ICD-10 code
  • Treatment history showing failed therapies with dates, doses, and outcomes
  • Recent lab results (CRP, ESR, CBC) showing inflammatory activity
  • Imaging reports (cardiac MRI for pericarditis; genetic testing for CAPS/DIRA)

Prior Authorization Forms

Submission Path

  1. Verify coverage through UnitedHealthcare provider portal
  2. Submit PA via OptumRx or provider portal (preferred method)
  3. Call for expedited review if urgent: 866-889-8054
  4. Track submission with reference number for follow-up
Timeline: UnitedHealthcare must respond within 72 hours for standard requests, 24 hours for urgent cases. If no response within timeframe, request is automatically approved.

If "Possibly Eligible" - Tests to Request

Additional Testing Needed

For Recurrent Pericarditis

  • Cardiac MRI to confirm pericardial inflammation
  • Complete inflammatory marker panel (CRP, ESR, troponin)
  • Echocardiogram to assess for complications

For CAPS/DIRA

  • Genetic testing for NLRP3 mutations (CAPS) or IL1RN mutations (DIRA)
  • Specialist consultation with immunologist or rheumatologist
  • Disease activity assessment tools

Timeline to Re-apply

  • Complete testing within 30-60 days
  • Schedule specialist follow-up to interpret results
  • Resubmit PA with comprehensive documentation package

If "Not Yet" - Alternatives to Discuss

Step Therapy Options

Before Arcalyst approval, you may need to try:

  1. NSAIDs (ibuprofen, indomethacin) for 8-12 weeks
  2. Colchicine 0.6mg twice daily for 3+ months
  3. Corticosteroids (prednisone) if NSAIDs/colchicine insufficient

Exception Requests

California's step therapy override law (AB 347) allows exceptions if:

  • Previous failure or intolerance to step drugs
  • Step drug contraindicated or likely to cause harm
  • You're stable on Arcalyst and switching would be harmful
  • Step drug not FDA-approved for your condition

If Denied - Appeal Path Chooser

Level 1: Peer-to-Peer Review

When to use: Within 24 hours of pre-service denial

  • Request through UnitedHealthcare provider portal
  • Your prescriber discusses case directly with UHC medical director
  • Often resolves denials without formal appeal

Level 2: Internal Appeal

Timeline: File within 60 days of denial notice

  • Submit via UHC Provider Portal (required for electronic submission)
  • Include enhanced medical necessity letter addressing denial reasons
  • Decision within 30 days (standard) or 72 hours (expedited)

Level 3: California Independent Medical Review (IMR)

When: After exhausting UnitedHealthcare internal appeals

  • File within 6 months through CA DMHC
  • Free, binding review by independent medical experts
  • 68% success rate for specialty drug appeals
  • Decision within 30-45 days (7 days expedited)
Appeal Level Filing Deadline Response Time Success Rate Cost
Peer-to-Peer 24 hours Immediate ~40% Free
Internal Appeal 60 days 30 days ~25% Free
CA DMHC IMR 6 months 30-45 days ~68% Free

Flowchart Visual

START: Need Arcalyst Coverage
    ↓
Confirmed FDA-approved diagnosis?
    ↓ YES                    ↓ NO
Specialist prescriber?       Get specialist consultation
    ↓ YES                    ↓
Failed step therapy?         Try required medications
    ↓ YES                    ↓
Submit PA with docs          Document failures/intolerance
    ↓                        ↓
APPROVED → Start treatment   DENIED → Appeal process

Download full decision flowchart (PDF) - Counterforce Health helps patients navigate complex prior authorization requirements by analyzing denial letters and creating targeted, evidence-based appeals that align with each payer's specific criteria.

Resources & Verification

Official Sources

Patient Support

  • Arcalyst Access & Support: Professional enrollment assistance
  • California Health Consumer Alliance: Free appeal guidance
  • DMHC Help Center: 888-466-2219 for IMR assistance
From our advocates: "We've seen the strongest Arcalyst approvals when specialists include specific lab values showing inflammatory activity and detailed documentation of colchicine failure, including exact doses tried and duration. Plans respond well to objective measures rather than subjective symptom reports."

FAQ

How long does UnitedHealthcare PA take in California? Standard requests: 72 hours. Urgent requests: 24 hours. If UnitedHealthcare doesn't respond within these timeframes, your request is automatically approved for the full prescription duration.

What if Arcalyst is non-formulary? You can request a formulary exception along with your PA. California law requires plans to have a clear exception process for medically necessary non-formulary drugs.

Can I request an expedited appeal? Yes, if delay would seriously jeopardize your health. Expedited appeals must be decided within 72 hours for internal appeals and 7 days for DMHC IMR.

Does step therapy apply if I failed treatments in another state? Yes, documented treatment failures from any location count toward California step therapy requirements, as long as you have medical records proving the trials and outcomes.

What's the cost difference between tiers? Arcalyst is typically a Tier 4 specialty drug with 25-40% coinsurance. Manufacturer copay assistance may reduce your cost to $5-10 per month if you qualify.

When should I contact California regulators? File a DMHC complaint if UnitedHealthcare misses response deadlines, denies clearly eligible cases, or fails to follow California step therapy override requirements.

Disclaimer: This information is for educational purposes and doesn't constitute medical advice. Coverage decisions depend on your specific plan benefits and medical circumstances. Consult your healthcare provider and review your plan documents for personalized guidance.

Need help navigating denials and appeals? Counterforce Health specializes in turning insurance denials into successful approvals by creating evidence-backed appeals tailored to each payer's requirements, helping patients access the medications they need.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.